Hypermethylation of adjacent CpG sites is negatively correlated with the expression of lineage oncogene in pulmonary neuroendocrine tumors

Achaete-scute homolog 1 is a lineage oncogene of high-grade pulmonary neuroendocrine tumors. Due to the relatively few studies investigating the epigenetic regulation of achaete-scute homolog 1 expression, we wanted to address whether DNA methylation of the achaete-scute homolog 1 CpG island is asso...

Full description

Saved in:
Bibliographic Details
Main Authors: Nhung Truong, Sung Min Chun, Tae Im Kim, Young Ah Suh, Se Jin Jang
Format: Article
Language:English
Published: SAGE Publishing 2017-05-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428317706225
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849411201270808576
author Nhung Truong
Sung Min Chun
Tae Im Kim
Young Ah Suh
Se Jin Jang
author_facet Nhung Truong
Sung Min Chun
Tae Im Kim
Young Ah Suh
Se Jin Jang
author_sort Nhung Truong
collection DOAJ
description Achaete-scute homolog 1 is a lineage oncogene of high-grade pulmonary neuroendocrine tumors. Due to the relatively few studies investigating the epigenetic regulation of achaete-scute homolog 1 expression, we wanted to address whether DNA methylation of the achaete-scute homolog 1 CpG island is associated with clinicopathological features in pulmonary neuroendocrine tumors and to investigate its effect on the expression of this gene. Here, We performed multiplex immunohistochemistry (PerkinElmer, Waltham, MA, USA) to check for achaete-scute homolog 1 and Notch homolog 1 expression in 139 pulmonary neuroendocrine tumor samples. Quantitative measurements of achaete-scute homolog 1 CpG island methylation were conducted using the MassARRAY EpiTYPER (Sequenom, San Diego, CA, USA). The correlation between immunohistochemistry data, methylation data, and clinicopathological information was analyzed. Achaete-scute homolog 1 methylation levels were increased in pulmonary neuroendocrine tumors compared to those in normal controls (0.107 vs 0.061, p < 0.001), and among the achaete-scute homolog 1 CpG island, only CpG_6 and CpG_7.8 showed higher methylation levels in pulmonary neuroendocrine tumors (0.208 and 0.135, respectively) compared to those in normal lung tissues (0.072 and 0.087, respectively; p < 0.001). Moreover, the methylation level of CpG_6.7.8 was higher in patients with stage I pulmonary neuroendocrine tumors than in patients with stage II/III pulmonary neuroendocrine tumors (0.19 ± 0.16 vs 0.14 ± 0.07, p = 0.012). The hypermethylation of CpG_6.7.8 showed an inverse correlation with achaete-scute homolog 1 protein expression (r = −0.408, p = 0.007, Spearman test). Finally, we found that CpG_6.7.8 of the achaete-scute homolog 1 CpG island is frequently hypermethylated in early-stage pulmonary neuroendocrine tumors, and this aberrant hypermethylation is negatively correlated with achaete-scute homolog 1 expression in this tumor spectrum.
format Article
id doaj-art-8c8528303cac40ff9d9dee57f72ca434
institution Kabale University
issn 1423-0380
language English
publishDate 2017-05-01
publisher SAGE Publishing
record_format Article
series Tumor Biology
spelling doaj-art-8c8528303cac40ff9d9dee57f72ca4342025-08-20T03:34:51ZengSAGE PublishingTumor Biology1423-03802017-05-013910.1177/1010428317706225Hypermethylation of adjacent CpG sites is negatively correlated with the expression of lineage oncogene in pulmonary neuroendocrine tumorsNhung Truong0Sung Min Chun1Tae Im Kim2Young Ah Suh3Se Jin Jang4Asan Medical Center, University of Ulsan College of Medicine, Seoul, South KoreaAsan Center for Cancer Genome Discovery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South KoreaAsan Center for Cancer Genome Discovery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South KoreaAsan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South KoreaAsan Center for Cancer Genome Discovery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South KoreaAchaete-scute homolog 1 is a lineage oncogene of high-grade pulmonary neuroendocrine tumors. Due to the relatively few studies investigating the epigenetic regulation of achaete-scute homolog 1 expression, we wanted to address whether DNA methylation of the achaete-scute homolog 1 CpG island is associated with clinicopathological features in pulmonary neuroendocrine tumors and to investigate its effect on the expression of this gene. Here, We performed multiplex immunohistochemistry (PerkinElmer, Waltham, MA, USA) to check for achaete-scute homolog 1 and Notch homolog 1 expression in 139 pulmonary neuroendocrine tumor samples. Quantitative measurements of achaete-scute homolog 1 CpG island methylation were conducted using the MassARRAY EpiTYPER (Sequenom, San Diego, CA, USA). The correlation between immunohistochemistry data, methylation data, and clinicopathological information was analyzed. Achaete-scute homolog 1 methylation levels were increased in pulmonary neuroendocrine tumors compared to those in normal controls (0.107 vs 0.061, p < 0.001), and among the achaete-scute homolog 1 CpG island, only CpG_6 and CpG_7.8 showed higher methylation levels in pulmonary neuroendocrine tumors (0.208 and 0.135, respectively) compared to those in normal lung tissues (0.072 and 0.087, respectively; p < 0.001). Moreover, the methylation level of CpG_6.7.8 was higher in patients with stage I pulmonary neuroendocrine tumors than in patients with stage II/III pulmonary neuroendocrine tumors (0.19 ± 0.16 vs 0.14 ± 0.07, p = 0.012). The hypermethylation of CpG_6.7.8 showed an inverse correlation with achaete-scute homolog 1 protein expression (r = −0.408, p = 0.007, Spearman test). Finally, we found that CpG_6.7.8 of the achaete-scute homolog 1 CpG island is frequently hypermethylated in early-stage pulmonary neuroendocrine tumors, and this aberrant hypermethylation is negatively correlated with achaete-scute homolog 1 expression in this tumor spectrum.https://doi.org/10.1177/1010428317706225
spellingShingle Nhung Truong
Sung Min Chun
Tae Im Kim
Young Ah Suh
Se Jin Jang
Hypermethylation of adjacent CpG sites is negatively correlated with the expression of lineage oncogene in pulmonary neuroendocrine tumors
Tumor Biology
title Hypermethylation of adjacent CpG sites is negatively correlated with the expression of lineage oncogene in pulmonary neuroendocrine tumors
title_full Hypermethylation of adjacent CpG sites is negatively correlated with the expression of lineage oncogene in pulmonary neuroendocrine tumors
title_fullStr Hypermethylation of adjacent CpG sites is negatively correlated with the expression of lineage oncogene in pulmonary neuroendocrine tumors
title_full_unstemmed Hypermethylation of adjacent CpG sites is negatively correlated with the expression of lineage oncogene in pulmonary neuroendocrine tumors
title_short Hypermethylation of adjacent CpG sites is negatively correlated with the expression of lineage oncogene in pulmonary neuroendocrine tumors
title_sort hypermethylation of adjacent cpg sites is negatively correlated with the expression of lineage oncogene in pulmonary neuroendocrine tumors
url https://doi.org/10.1177/1010428317706225
work_keys_str_mv AT nhungtruong hypermethylationofadjacentcpgsitesisnegativelycorrelatedwiththeexpressionoflineageoncogeneinpulmonaryneuroendocrinetumors
AT sungminchun hypermethylationofadjacentcpgsitesisnegativelycorrelatedwiththeexpressionoflineageoncogeneinpulmonaryneuroendocrinetumors
AT taeimkim hypermethylationofadjacentcpgsitesisnegativelycorrelatedwiththeexpressionoflineageoncogeneinpulmonaryneuroendocrinetumors
AT youngahsuh hypermethylationofadjacentcpgsitesisnegativelycorrelatedwiththeexpressionoflineageoncogeneinpulmonaryneuroendocrinetumors
AT sejinjang hypermethylationofadjacentcpgsitesisnegativelycorrelatedwiththeexpressionoflineageoncogeneinpulmonaryneuroendocrinetumors